Literature DB >> 118706

Agar disk diffusion susceptibility characteristics of azlocillin, carbenicillin, mezlocillin, piperacillin, and ticarcillin.

D Phaneuf, H C Neu.   

Abstract

The agar disk diffusion susceptibility of Enterobacteriaceae to mezlocillin and piperacillin was correlated with agar minimal inhibitory concentrations and compared with the susceptibility to carbenicillin. The agar disk susceptibility of Pseudomonas aeruginosa to azlocillin, mezlocillin, and piperacillin was correlated with agar minimal inhibitory concentrations and compared with the susceptibility to carbenicillin and ticarcillin. Criteria are offered for the zones of inhibition to provide information about resistant and susceptible isolates that correlate with known serum levels.

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 118706      PMCID： PMC352917          DOI： 10.1128/AAC.16.5.625

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  11 in total

1.  Proposed ticarcillin disk control values for Escherichia coli and Pseudomonas aeruginosa: multicenter cooperative study.

Authors:  R B Prior; R J Fass
Journal:  Antimicrob Agents Chemother       Date:  1978-09       Impact factor: 5.191

2.  Comparative in vitro activity and clinical pharmacology of ticarcillin and carbenicillin.

Authors:  H C Neu; G J Garvey
Journal:  Antimicrob Agents Chemother       Date:  1975-10       Impact factor: 5.191

3.  Piperacillin, a new penicillin active against many bacteria resistant to other penicillins.

Authors:  K P Fu; H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1978-03       Impact factor: 5.191

4.  In vitro activity of piperacillin, a new semisynthetic penicillin with an unusually broad spectrum of activity.

Authors:  L Verbist
Journal:  Antimicrob Agents Chemother       Date:  1978-03       Impact factor: 5.191

5.  Piperacillin (T-1220), a new semisynthetic penicillin: in vitro antimicrobial activity comparison with carbenicillin, ticarcillin, ampicillin, cephalothin, cefamandole and cefoxitin.

Authors:  R N Jones; C Thornsberry; A L Barry; P C Fuchs; T L Gavan; E H Gerlach
Journal:  J Antibiot (Tokyo)       Date:  1977-12       Impact factor: 2.649

6.  Comparison and evaluation of ticarcillin and carbenicillin using disk diffusion methods.

Authors:  M F Parry; H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1976-04       Impact factor: 5.191

7.  Kinetics of mezlocillin and carbenicillin.

Authors:  S J Pancoast; H C Neu
Journal:  Clin Pharmacol Ther       Date:  1978-07       Impact factor: 6.875

8.  Azlocillin and mezlocillin: new ureido penicillins.

Authors:  K P Fu; H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1978-06       Impact factor: 5.191

9.  In vitro studies of piperacilin, a new semisynthetic penicillin.

Authors:  D J Winston; D Wang; L S Young; W J Martin; W L Hewitt
Journal:  Antimicrob Agents Chemother       Date:  1978-06       Impact factor: 5.191

10.  Pharmacokinetics of azlocillin in persons with normal and impaired renal functions.

Authors:  P Fiegel; K Becker
Journal:  Antimicrob Agents Chemother       Date:  1978-09       Impact factor: 5.191
View more
  11 in total

1.  Activity of apalcillin against Pseudomonas aeruginosa.

Authors:  G E Hollick; J Gundrum; R A Venezia
Journal:  Antimicrob Agents Chemother       Date:  1984-09       Impact factor: 5.191

2.  Sensitivity of 341 non-fermentative gram-negative bacteria to seven beta-lactam antibiotics.

Authors:  P C Appelbaum; J Tamim; J Stavitz; R C Aber; G A Pankuch
Journal:  Eur J Clin Microbiol       Date:  1982-06       Impact factor: 3.267

3.  Susceptibility and tolerance of beta-lactamase-producing, methicillin-sensitive strains of Staphylococcus aureus towards seven broad-spectrum penicillins.

Authors:  R Wehrli; A von Graevenitz; R Lüthy
Journal:  Infection       Date:  1983 Nov-Dec       Impact factor: 3.553

4.  Comparative in vitro appraisal of piperacillin, including its activity against Salmonella typhi.

Authors:  R G Robinson; J Saunders; R Cassel; C S Block; H J Koornhof
Journal:  Antimicrob Agents Chemother       Date:  1980-10       Impact factor: 5.191

Review 5.  Ticarcillin: a review of its pharmacological properties and therapeutic efficacy.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1980-11       Impact factor: 9.546

6.  In vitro comparison of N-formimidoyl thienamycin (MK0787) and Azlocillin with three aminoglycosides and ticarcillin against Pseudomonas aeruginosa.

Authors:  A J Matzkowitz; A L Baltch; R P Smith; N T Sutphen; M C Hammer; J V Conroy
Journal:  Antimicrob Agents Chemother       Date:  1982-04       Impact factor: 5.191

7.  Quality control and interpretive criteria for the azlocillin disk diffusion susceptibility test.

Authors:  R J Fass
Journal:  Antimicrob Agents Chemother       Date:  1982-07       Impact factor: 5.191

8.  Mezlocillin susceptibility tests by the single-disk agar diffusion method.

Authors:  R J Fass; R B Prior
Journal:  Antimicrob Agents Chemother       Date:  1981-02       Impact factor: 5.191

9.  Correlation of moxalactam (LY127935) susceptibility tests by disk diffusion and agar plate dilution methods.

Authors:  W H Hall; B J Opfer
Journal:  Antimicrob Agents Chemother       Date:  1981-01       Impact factor: 5.191

10.  Mezlocillin: tentative interpretive standards for disk diffusion susceptibility testing.

Authors:  P C Fuchs; A L Barry; C Thornsberry; R N Jones; E H Gerlack
Journal:  Antimicrob Agents Chemother       Date:  1981-08       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.